Related Experiment Videos
[Clinical experiences with pectoral defibrillator implantation]
Summary
The new PCD 7219 D/C cardioverter-defibrillator allows for pectoral implantation in most patients. Its "active-can" system requires fewer leads and achieves lower defibrillation thresholds.
Area of Science:
- Cardiology
- Biomedical Engineering
Context:
- Transvenous defibrillation systems aim for simplified implantation.
- The fourth-generation PCD 7219 D/C cardioverter-defibrillator is designed for pectoral implantation.
- Device characteristics include a weight of 132g, size of 89x64x18mm, volume of 83cm³, and surface area of 108cm².
Purpose:
- To evaluate the feasibility and outcomes of pectoral implantation of the PCD 7219 D/C cardioverter-defibrillator.
- To assess the efficacy of the
- active-can
- system in reducing defibrillation thresholds.
Summary:
- Subpectoral implantation was successful in 79% of 75 patients with ventricular tachyarrhythmias.
- Male sex, body weight, and body surface were predictors of successful pectoral implantation.
- The
- active-can
- system demonstrated significantly lower defibrillation thresholds (9.9 ± 6.5 J) compared to dual lead systems (19 ± 4.5 J).
- Lead dislodgement occurred in two patients, necessitating revision.
Impact:
- The down-sized PCD 7219 D/C facilitates pectoral implantation in a majority of patients.
- The
- active-can
- system simplifies implantation by requiring only one right ventricular lead.
- This approach leads to significantly lower defibrillation thresholds, potentially improving patient outcomes.